Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Biotechnology and Applied Biochemistry|August 13, 2003
The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutininTino Krell, Frédéric Greco, Marie-Claire Nicolaï, et al.
Frontiers in Immunology|September 30, 2017
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier DysfunctionThomas Secher, Sahar Kassem, Mehdi Benamar, et al.
BMC Cancer|September 9, 2017
IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancerYann Neuzillet, Elodie Chapeaublanc, Clémentine Krucker, et al.
Plos One|April 22, 2009
CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patientsLaurence Ordonez, Isabelle Bernard, Fatima-Ezzahra L'faqihi-Olive, et al.
The American Journal of Pathology|September 21, 2013
PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumorsSardar F Mahmood, Nadège Gruel, Rémy Nicolle, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activationCatherine François, Isabelle Bernard, Sandrine Castelain, et al.
Cancers|January 5, 2021
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and PerspectivesLinda Silina, Fatlinda Maksut, Isabelle Bernard-Pierrot, et al.
Genome Medicine|September 29, 2020
Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancerMing-Jun Shi, Xiang-Yu Meng, Jacqueline Fontugne, et al.
Journal of Medical Virology|September 10, 2010
Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapyCatherine François, Véronique Descamps, Etienne Brochot, et al.
Blood|July 24, 2004
Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulationEmmanuel Xystrakis, Anne S Dejean, Isabelle Bernard, et al.
Pageof 9